DAPT Score (Dual Antiplatelet Therapy) Calculator

Clinical calculation support · Verify results before clinical use

Calculate the patient's score

Select each clinical or procedural feature. The score is intended to support reassessment after 12 months of dual antiplatelet therapy.

— DAPT score
Age contributes negative points in the original DAPT Score.
−2 to 0 points
Current cigarette smokingCurrently smoking cigarettes at the time of assessment.+1 point
Diabetes mellitusA diagnosis of diabetes mellitus.+1 point
Myocardial infarction at presentationThe index PCI presentation was myocardial infarction.+1 point
Prior PCI or myocardial infarctionHistory of prior PCI or myocardial infarction.+1 point
Stent diameter less than 3 mmAt least one implanted stent has a diameter below 3 mm.+1 point
Paclitaxel-eluting stentA paclitaxel-eluting stent was used.+1 point
Congestive heart failure or LVEF below 30%Congestive heart failure or left ventricular ejection fraction below 30%.+2 points
Saphenous vein graft stentA stent was placed in a saphenous vein graft.+2 points
Reset form

About the DAPT Score

The Dual Antiplatelet Therapy (DAPT) Score was developed to help estimate the balance of ischemic benefit and bleeding harm associated with continuing dual antiplatelet therapy beyond one year after coronary stent implantation. It is an aid to clinical decision-making, not a substitute for individualized assessment.

Score components

VariableCriterionPoints
Age75 years or older−2
Age65–74 years−1
AgeYounger than 65 years0
Current cigarette smokingYes+1
Diabetes mellitusYes+1
MI at presentationYes+1
Prior PCI or MIYes+1
Stent diameterLess than 3 mm+1
Paclitaxel-eluting stentYes+1
CHF or LVEF below 30%Yes+2
Saphenous vein graft stentYes+2

Interpreting the result

A score of 2 or greater was associated with a more favorable balance for extended DAPT in the score's derivation and validation cohorts; a score below 2 was associated with less favorable net benefit. The score does not quantify an individual's absolute risk and should not be used alone to prescribe or stop antiplatelet therapy.

References

Yeh RW, Secemsky EA, Kereiakes DJ, et al.Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735–1749. DOI: 10.1001/jama.2016.3775.
Mauri L, Kereiakes DJ, Yeh RW, et al.; DAPT Study Investigators.Twelve or 30 Months of Dual Antiplatelet Therapy After Drug-Eluting Stents. N Engl J Med. 2014;371:2155–2166. DOI: 10.1056/NEJMoa1409312.
Clinical disclaimer: This calculator is intended for use by qualified healthcare professionals as a decision-support aid. The DAPT Score should be applied in the appropriate post-PCI context and interpreted alongside bleeding risk, ischemic risk, current guidelines, and patient-specific factors. Do not make treatment changes based on the score alone.